From Wikipedia, the free encyclopedia
Content deleted Content added
Latest revision as of 15:18, 15 October 2025
| Peer review
Complete your peer review exercise below, providing as much constructive criticism as possible. The more detailed suggestions you provide, the more useful it will be to your classmate. Make sure you consider each of the following aspects: LeadGuiding questions:
ContentGuiding questions:
Tone and BalanceGuiding questions:
Sources and ReferencesGuiding questions:
OrganizationGuiding questions:
Images and MediaGuiding questions: If your peer added images or media
For New Articles OnlyIf the draft you’re reviewing is for a new article, consider the following in addition to the above.
Overall impressionsGuiding questions:
Examples of good feedbackA good article evaluation can take a number of forms. The most essential things are to clearly identify the biggest shortcomings, and provide specific guidance on how the article can be improved. Additional ResourcesCheck out the Editing Wikipedia PDF for general editing tips and suggestions. |
- Whose work are you reviewing?
(provide username)
- Link to draft you’re reviewing
- Link to the current version of the article (if it exists)
Evaluate the drafted changes
[edit]
I like your proposed changes! I agree with you that there shouldn’t be an overview of pharmacodynamics, maybe a one sentence description and a link to the main wiki page for pharmacodynamics would be more suitable.
I also agree with you that the medical uses section should be more expanded. It felt like the article kept on only referencing Parkinson’s disease treatments throughout, which made the article sound like a Parkinson’s disease article rather than a dopamine agonist one. I think just being able to link what the paper talks about with other drugs and diseases would benefit the article a lot.
If you are can find some, maybe some papers describing general trends that all dopamine agonists share would be beneficial so that the paper doesn’t feel like a large summary of a lot of different drugs without a link between them. For example, why are do “Dopamine agonists have two subclasses: ergoline and non-ergoline agonists”? I feel like this could be a in the intro header or section in itself instead of within the subsection of Parkinson’s disease without an explanation of the theory behind it. Also, something you could add is a very short definition of what an agonist is, since it is very relevant to the article topic, and might help readers understand the article better.
I agree with you that there is a lot of information repeated, and I think a bit of a clean up would help this article a lot. I like your sources and proposed changes, and I think you’re off to a really good start!


